174
V. Novakova et al. / Dyes and Pigments 87 (2010) 173e179
The MALDI-TOF mass spectra were collected on a Voyager-DE STR
mass spectrometer (Applied Biosystems, Framingham, MA, USA)
calibrated externally with a five-point calibration procedure using
Peptide Calibration Mix1 (LaserBio Labs, Sophia-Antipolis, France). A
solution of TPyPz in DCM (approximate concentration
1 ꢀ 10ꢁ5 mol Lꢁ1, 1.5 ꢀ 10ꢁ3 mL) was mixed with trans-2-[3-(4-tert-
butylphenyl)-2-methyl-2-propenylidene]-malononitrile matrix in
DCM (0.01 mL, 1 mg/0.5 mL) and spotted on the plate.
114.3, 121.9, 124.5, 128.9, 142.1, 151.4, 153.3 ppm. IR (ATR):
nmax ¼ 3303, 2936, 2873, 2233 (CN), 1729, 1701, 1598, 1544, 1501,
1441, 1400, 1374, 1350, 1237, 1194, 1153, 1105, 1039, 1011, 941, 924,
858, 847 and 809 cmꢁ1. Elemental analysis calc. (%) for C20H14N4O4:
C, 64.17; H, 3.77; N, 14.97; found: C, 62.45; H, 4.25; N, 14.37.
2.1.4. Alternative preparation of 5,6-bis(4-(hydroxymethyl)
phenoxy)pyrazine-2,3-dicarbonitrile (5)
NaOH (100 mg, 2.5 mmol) was dissolved in water (20 mL) and
4-(hydroxymethyl)phenol (311 mg, 2.5 mmol) was added. The
suspension was sonicated and stirred for 20 min at room temper-
ature and ethanol (10 mL) was added to expedite solubilisation.
Thereafter, compound 1 (200 mg, 1.0 mmol) in tetrahydrofuran
(10 mL) was added dropwise and the ensuing solution was stirred
for 10 min at room temperature. Ethanol and tetrahydrofuran were
evaporated and the mixture was diluted with water (70 mL) and
extracted three times with ethylacetate (3 ꢀ 100 mL). The organic
layer was dried over anhydrous Na2SO4, filtered and evaporated
under reduced pressure to dryness. The mixture was purified by
column chromatography on silica with chloroform/acetone 10:1.
The two important fractions were isolated, one corresponding to 5
(Rf ¼ 0.15, white solid, 86 mg, 23%) and the second was 5,6-bis
(ethoxy)pyrazine-2,3-dicarbonitrile (Rf ¼ 0.79, a pale yellow solid,
89 mg, 41%; m.p. 112.2e113.0 ꢂC, lit.[28] 117e118 ꢂC). 1H NMR
2.1. Synthesis
5,6-Dichloropyrazine-2,3-dicarbonitrile (1) [25], 5,6-bis(butoxy)
pyrazine-2,3-dicarbonitrile (2) [26] and Zn(quinoline)2Cl2 (ZnQ2Cl2)
[27] were prepared according to published procedures.
2.1.1. 5,6-Bis(octyloxy)pyrazine-2,3-dicarbonitrile (3)
A solution of triethylamine (895 mg, 8.84 mmol) in anhydrous
octanol (6 mL) was stirred for 45 min at room temperature and
added dropwise to a suspension of 1 (800 mg, 4 mmol) in anhy-
drous octanol (25 mL). The suspension dissolved after approxi-
mately 15 min and stirring was continued for 60 min at room
temperature. Octanol was then removed under reduced pressure
and the crude product was purified by column chromatography on
silica using toluene/hexane 2:1 as eluent, to provide a yellow oil
(785 mg, 51%). 1H NMR (300 MHz, CDCl3, 25 ꢂC):
d
¼ 0.89 (t, 6 H,
(300 MHz, (CD3)2CO, 25 ꢂC):
d
¼ 1.43 (t, 6 H, J ¼ 7.1 Hz, CH3),
J ¼ 6.6 Hz, CH3), 1.25e1.45 (m, 20 H, CH2), 1.83 (p, 4 H, J ¼ 7.0 Hz,
4.54 ppm (q, 4 H, J ¼ 7.1 Hz, OCH2). 13C NMR (75 MHz, (CD3)2CO,
OCH2CH2) and 4.45 (t, 4 H, J ¼ 6.7 Hz, OCH2) ppm. 13C NMR (75 MHz,
25 ꢂC):
d
¼ 14.15, 65.82, 114.81, 123.34 and 153.16 ppm.
CDCl3, 25 ꢂC):
d
¼ 14.06, 22.61, 25.72, 28.16, 29.11 (4 carbons
according to rough integration), 31.72, 69.49, 113.49, 122.57 and
2.1.5. 2,3,9,10,16,17,23,24-Octakis(butoxy)-1,4,8,11,15,18,22,25-
151.95 ppm. IR (ATR): nmax ¼ 2953, 2924, 2855, 2236 (CN), 1549,
(octaaza)phthalocyanine zinc (II) (6)
1495, 1458, 1379, 1344, 1299, 1239, 948 cmꢁ1
.
Precursor 2 (80 mg, 0.29 mmol) and ZnQ2Cl2 (115 mg,
0.29 mmol) were mixed in a round bottom flask and heated at
190 ꢂC for 60 min. The crude product was dissolved in chloroform
(100 mL), filtered and the solvent removed under reduced pressure.
The solid was then washed with water/methanol 1:1 (300 mL),
adsorbed on silica and thoroughly washed with methanol (300 mL)
on a glass frit. Afterwards, the product was purified by column
chromatography on silica using chloroform as eluent to give a blue
solid (12 mg, 14%). NMR, IR, UVevis spectra showed the same
characteristics as described in the literature for this compound
prepared using different approach [26]. MS (MALDI-TOF) m/z 1160
[M]þ,1183 [M þ Na]þ,1199 [M þ K]þ, 2321 [2M]þ, 2344 [2M þ Na]þ,
2360 [2M þ K]þ.
2.1.2. 5,6-Bis(2,6-diisopropylphenoxy)pyrazine-
2,3-dicarbonitrile (4)
2,6-Diisopropylphenol (446 mg, 2.5 mmol) was stirred for 15 min
in an aqueous solution of sodium hydroxide (c ¼ 1 mol dmꢁ3, 2.4 mL,
2.4 mmol,). Compound 1 (200 mg,1 mmol) inTHF (15 mL) was added
dropwise and the mixture stirred for 30 min at room temperature.
The crude product was concentrated to dryness and the brownish-
yellow solid washed thoroughly with water (200 mL) and purified
using column chromatography on silica with toluene/hexane 1:1,
providing awhite solid (404 mg, 83%, mp 208.5e209.5 ꢂC (methanol),
lit. [22] 253 ꢂC (n-hexane)). 1H NMR (300 MHz, CDCl3, 25 ꢂC):
d
¼ 7.39e7.24 (m, 6H, aromH), 2.82 (sept, 4 H, J ¼ 7 Hz, CH),1.23 ppm
(d, 24H, J ¼ 7 Hz, CH3). 13C NMR (75 MHz, CDCl3, 25 ꢂC):
d
¼ 23.2, 28.0,
2.1.6. 2,3,9,10,16,17,23,24-Octakis(octyloxy)-1,4,8,11,15,18,22,25-
(octaaza)phthalocyanine zinc (II) (7)
112.6, 124.2, 124.6, 127.6, 139.8, 146.3, 151.1 ppm. IR (KBr):
nmax ¼ 3068, 3032, 2967, 2930, 2871, 2360, 2344, 2237, 1545, 1460,
1441, 1403, 1385, 1357, 1331, 1258, 1233, 1142, 1112, 1089, 1062, 937,
849, 793 and 750 cmꢁ1. Elemental analysis calc. (%) for C30H34N4O2: C,
74.66, H, 7.10, N, 11.61; found: C, 74.40; H, 7.31; N, 11.99.
ZnQ2Cl2 (153 mg, 0.39 mmol) was transferred to a round bottom
flask, 3 (150 mg, 0.39 mmol) was added and the mixture heated at
190 ꢂC for 60 min. The crude product was dissolved in chloroform
(100 mL), filtered and the solvent removed under reduced pressure.
The solid was then washed with water/methanol 1:1 (300 mL),
adsorbed on silica and thoroughly washed with methanol (300 mL)
on a glass frit. The product was purified using column chroma-
tography on silica with chloroform as eluent. The pure product was
dissolved in chloroform (1 mL), added dropwise to methanol
(50 mL) and the precipitate collected, giving a blue-green solid
(31 mg, 20%). 1H NMR (300 MHz, CDCl3/C5D5N, 25 ꢂC):
2.1.3. 5,6-Bis(4-(hydroxymethyl)phenoxy)pyrazine-
2,3-dicarbonitrile (5)
Compound 1 (400 mg, 2 mmol) was dissolved in THF (10 mL)
and then 4-(hydroxymethyl)phenol (1.24 g, 10.0 mmol) and pyri-
dine (695 mg, 8.8 mmol) were added. After 24 h of stirring at room
temperature the solvent was evaporated and the resulting yellow
oil was dissolved in chloroform (150 mL) and extracted three times
with brine (3 ꢀ 100 mL). The organic layer was dried over anhy-
drous Na2SO4. The crude product was purified by column chro-
matography on silica with ethylacetate/hexane 5:2 and
recrystallized from EtOH/H2O, yielding a white solid (486 mg, 65%,
d
¼ 0.50e0.58 (m, 24 H, CH3), 0.68e1.21 (m, 64 H, CH2), 1.22e1.45
(m, 16H, CH2), 1.59e1.91 (m, 16H, CH2), 4.28e4.85 ppm (m, 16 H,
OCH2). 13C NMR (75 MHz, CDCl3/C5D5N, 25 ꢂC):
d
¼ 13.20, 21.79,
25.53, 28.21, 28.54, 28.80, 31.03, 67.49, 139.48, 147.31 and
151.45 ppm. IR (ATR): nmax ¼ 2954, 2921, 2853, 1638, 1541, 1444,
1377, 1303, 1252, 1121, 1062, 960 cmꢁ1. UV/Vis (pyridine): lmax
m.p. 150.1e152.5 ꢂC). 1H NMR (300 MHz, (CD3)2CO, 25 ꢂC):
d
¼ 4.33
(t, 2 H, J ¼ 5.8 Hz, OH), 4.69 (d, 4H, J ¼ 5.8 Hz, CH2) 7.31 ppm (d, 4H,
(3
) ¼ 624 (199 700), 599 sh (31 500), 568 (28 400), 369 nm
J ¼ 8.6 Hz, aromH). 13C NMR (75 MHz, (CD3)2CO, 25 ꢂC):
d
¼ 64.0,
(134 300 dm3 molꢁ1 cmꢁ1). MS (MALDI-TOF): m/z 1609 [M]þ,